Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling

Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a primary contributor to liver‐related morbidity and mortality. Asprosin has been reported to be implicated in NAFLD. Aims This work is to illuminate the effects of Asprosin on NAFLD and the possible downstream mechanism. Materials & Me...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Bo Zhang, Jinger Lu, Yuhua Jiang, Yan Feng
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2023-08-01
Rangatū:	Immunity, Inflammation and Disease
Ngā marau:	AMPK signaling Asprosin inflammatory response lipid accumulation nonalcoholic fatty liver disease
Urunga tuihono:	https://doi.org/10.1002/iid3.947
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!